These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 28452560)

  • 1. Effects of a cardiac rehabilitation programme on plasma cardiac biomarkers in patients with chronic heart failure.
    Billebeau G; Vodovar N; Sadoune M; Launay JM; Beauvais F; Cohen-Solal A
    Eur J Prev Cardiol; 2017 Jul; 24(11):1127-1135. PubMed ID: 28452560
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic performance and reference values of novel biomarkers of paediatric heart failure.
    Hauser JA; Demyanets S; Rusai K; Goritschan C; Weber M; Panesar D; Rindler L; Taylor AM; Marculescu R; Burch M; Wojta J; Michel-Behnke I
    Heart; 2016 Oct; 102(20):1633-9. PubMed ID: 27220692
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved Exercise Capacity After Cardiac Rehabilitation Is Associated with Reduced Visceral Fat in Patients with Chronic Heart Failure.
    Takagawa Y; Yagi S; Ise T; Ishii A; Nishikawa K; Fukuda D; Kusunose K; Matsuura T; Tobiume T; Yamaguchi K; Yamada H; Soeki T; Wakatsuki T; Shimabukuro M; Katoh S; Aihara KI; Akaike M; Sata M
    Int Heart J; 2017 Oct; 58(5):746-751. PubMed ID: 28966316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MR-proANP, MR-proADM, and PCT in Patients Presenting with Acute Dyspnea in a Medical Emergency Unit.
    Heining L; Giesa C; Ewig S
    Lung; 2016 Apr; 194(2):185-91. PubMed ID: 26748496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial.
    Maisel A; Mueller C; Nowak R; Peacock WF; Landsberg JW; Ponikowski P; Mockel M; Hogan C; Wu AH; Richards M; Clopton P; Filippatos GS; Di Somma S; Anand I; Ng L; Daniels LB; Neath SX; Christenson R; Potocki M; McCord J; Terracciano G; Kremastinos D; Hartmann O; von Haehling S; Bergmann A; Morgenthaler NG; Anker SD
    J Am Coll Cardiol; 2010 May; 55(19):2062-76. PubMed ID: 20447528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adaptive cardiovascular hormones in a spectrum of heart failure phenotypes.
    Zabarovskaja S; Hage C; Linde C; Daubert JC; Donal E; Gabrielsen A; Mellbin L; Lund LH
    Int J Cardiol; 2015; 189():6-11. PubMed ID: 25885866
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure.
    Gegenhuber A; Struck J; Dieplinger B; Poelz W; Pacher R; Morgenthaler NG; Bergmann A; Haltmayer M; Mueller T
    J Card Fail; 2007 Feb; 13(1):42-9. PubMed ID: 17339002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between biomarkers and left ventricular filling pressures at rest and during exercise in patients after myocardial infarction.
    Andersen MJ; Ersbøll M; Bro-Jeppesen J; Møller JE; Hassager C; Køber L; Borlaug BA; Goetze JP; Gustafsson F
    J Card Fail; 2014 Dec; 20(12):959-67. PubMed ID: 25285749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MR-proADM Predicts Exercise Capacity and Survival Superior to Other Biomarkers in PH.
    Kolditz M; Seyfarth HJ; Wilkens H; Ewert R; Bollmann T; Dinter C; Hertel S; Klose H; Opitz C; Grünig E; Höffken G; Halank M
    Lung; 2015 Dec; 193(6):901-10. PubMed ID: 26363916
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic potential of midregional pro-adrenomedullin following decompensation for systolic heart failure: comparison with cardiac natriuretic peptides.
    Morbach C; Marx A; Kaspar M; Güder G; Brenner S; Feldmann C; Störk S; Vollert JO; Ertl G; Angermann CE;
    Eur J Heart Fail; 2017 Sep; 19(9):1166-1175. PubMed ID: 28516504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cross-talk between the heart and adipose tissue in cachectic heart failure patients with respect to alterations in body composition: a prospective study.
    Christensen HM; Kistorp C; Schou M; Keller N; Zerahn B; Frystyk J; Flyvbjerg A; Faber J
    Metabolism; 2014 Jan; 63(1):141-9. PubMed ID: 24140097
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers and diagnostics in heart failure.
    Gaggin HK; Januzzi JL
    Biochim Biophys Acta; 2013 Dec; 1832(12):2442-50. PubMed ID: 23313577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic Value of Serial Measurements of Soluble Suppression of Tumorigenicity 2 and Galectin-3 in Ambulatory Patients With Chronic Heart Failure.
    Miller WL; Saenger AK; Grill DE; Slusser JP; Bayes-Genis A; Jaffe AS
    J Card Fail; 2016 Apr; 22(4):249-55. PubMed ID: 26277907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurohormonal activation and exercise tolerance in patients supported with a continuous-flow left ventricular assist device.
    Jung MH; Goetze JP; Boesgaard S; Gustafsson F
    Int J Cardiol; 2016 Oct; 220():196-200. PubMed ID: 27379923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Baduanjin exercise for patients with ischemic heart failure on phase-II cardiac rehabilitation (BEAR trial): study protocol for a prospective randomized controlled trial.
    Yu M; Li S; Li S; Li J; Xu H; Chen K
    Trials; 2018 Jul; 19(1):381. PubMed ID: 30012193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma concentrations of novel cardiac biomarkers before and after hemodialysis session.
    Mueller T; Gegenhuber A; Kronabethleitner G; Leitner I; Haltmayer M; Dieplinger B
    Clin Biochem; 2015 Nov; 48(16-17):1163-6. PubMed ID: 26232288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivering effective, comprehensive, multi-exercise component cardiac rehabilitation (CR) for chronic heart failure patients in low resource settings in sub-Saharan Africa: Queen Elizabeth Central Hospital-(QECH-CR) randomised CR study, Malawi.
    Namanja A; Nyondo D; Banda T; Mndinda E; Midgely A; Hobkirk J; Carroll S; Kumwenda J
    PLoS One; 2024; 19(5):e0297564. PubMed ID: 38787817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Midregional proadrenomedullin and growth differentiation factor-15 are not influenced by obesity in heart failure patients.
    Sinning C; Ojeda F; Wild PS; Schnabel RB; Schwarzl M; Ohdah S; Lackner KJ; Pfeiffer N; Michal M; Blettner M; Munzel T; Kempf T; Wollert KC; Kuulasmaa K; Blankenberg S; Salomaa V; Westermann D; Zeller T
    Clin Res Cardiol; 2017 Jun; 106(6):401-410. PubMed ID: 28004184
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac rehabilitation program in patients with Chagas heart failure: a single-arm pilot study.
    Mediano MF; Mendes Fde S; Pinto VL; Silva GM; Silva PS; Carneiro FM; Sangenis LH; Saraiva RM; Xavier SS; Brasil PE; Hasslocher-Moreno AM; Sousa AS
    Rev Soc Bras Med Trop; 2016; 49(3):319-28. PubMed ID: 27384829
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac Rehabilitation Participation Rates and Outcomes for Patients With Heart Failure.
    Rengo JL; Savage PD; Barrett T; Ades PA
    J Cardiopulm Rehabil Prev; 2018 Jan; 38(1):38-42. PubMed ID: 28671938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.